Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MenHibrix vs ActHIB in Infants
NCT00129129Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2004
- Primary completion
- Sep 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen in Haemophilus influenzae type b infection (Hib), meningococcal disease, sponsored by GSK. Started Aug 2004; status: completed.
02
Drugs
haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen
03
Conditions
Haemophilus influenzae type b infection (Hib)meningococcal disease
Beyond the preview
Go deeper on NCT00129129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129129.